Theravance Biopharma, Inc. (TBPH)
16.02
+0.18
(+1.14%)
USD |
NASDAQ |
Apr 02, 16:00
16.01
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma Research and Development Expense (TTM) : 35.79M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Integer Holdings Corp. | 49.50M |
| QuidelOrtho Corp. | 186.20M |
| Viatris, Inc. | 941.10M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Nektar Therapeutics | 117.30M |